Abstract

Rationale: Use of biologics in severe asthma has grown dramatically in the last decade; however, little is known about the patterns of biologic use in real-life.
Original languageEnglish
Article numberA7739
Number of pages2
JournalAmerican Journal of Respiratory and Critical Care Medicine
Volume201
Issue numberD103
DOIs
Publication statusPublished - 2020

Bibliographical note

This abstract is funded by: ISAR is conducted by Optimum Patient Care Global Limited, and co-funded by OPC Global and AstraZeneca

Fingerprint

Dive into the research topics of 'Biologic Utilization Patterns: Data from the International Severe Asthma Registry (ISAR)'. Together they form a unique fingerprint.

Cite this